°¡Å縯 ¾Ï¼¾ÅÍ ½ÉÆ÷Áö¿ò ¾È³»
| » ÀÛ¼ºÀÚ : |
» ÀÛ¼ºÀÏ : 2005-12-16 |
» Á¶È¸ : 2303 |
|
| » ÷ºÎÆÄÀÏ : |
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù. |
|
ÀÏ ½Ã: 2006 ³â 1¿ù 14ÀÏ(Åä¿äÀÏ)
Àå ¼Ò: °¡Å縯ÀǰúÇпø 2Ãþ ´ë°´ç
Clinical Implications of Cancer Vaccine
9;00-9:05 °³È¸»ç È«¿ë±æ±³¼ö (°¡Å縯¾Ï¼¾ÅÍ ¼ÒÀå)
9:05-9:10 Ãà »ç ±è½Â³²±³¼ö(°³²¼º¸ðº´¿ø º´¿øÀå)
I. Basic Concept and Current Issues of Cancer Vaccine
09:10-09:30 Overview ¼º¿µÃ¶±³¼ö(Æ÷Ç×°ø´ë »ý¸í°úÇкÎ)
Gene-Based Vaccine
ÁÂÀå ¾È¿õ½Ä±³¼ö(°¡Å縯ÀÇ´ë »êºÎÀΰú)
09:30-09:55 DNA Vaccine ±èÅ¿챳¼ö(°í·ÁÀÇ´ë ´ëÇпø)
09:55-10:20 Viral and Bacterial Vaccine
¼Û¸¸±â¹Ú»ç (±¹Á¦¹é½Å¿¬±¸¼Ò)
10:20-10:30 Question and Answer
10:30-11:00 Coffee-break
Cell-Based Vaccine ÁÂÀå °Ã¢À²±³¼ö (¼¿ï´ë ¾à´ë)
11:00-11:25 Dendritic cell based Vaccine
±èűԱ³¼ö (°¡Å縯ÀÇ´ë ¹Ì»ý¹°Çаú)
11:25-11:50 T-cell based Vaccine
ÀåÁر³¼ö (ÀÌÈ¿©´ë ¾àÇдëÇÐ)
11:50-12:00 Question and Answer
12:00-13:30 Lunch
I. Clinical Implications of Human Papillomavirus (HPV) Vaccine
13:30-13:50 Overview ¹ÚÁ¾¼·±³¼ö(°¡Å縯ÀÇ´ë»êºÎÀΰú)
Prophylactic HPV Vaccine
ÁÂÀå ° ¼ø¹ü±³¼ö (¼¿ïÀÇ´ë »êºÎÀΰú)
13:50-14:40 Merck HPV Vaccine(Gardasil)
Dr. Gregg Sylvester (MSD)
14:40-15:30 GSK HPV Vaccine (Cervarix)
Dr. Hans Bock (GSK)
15:30-15:40 Question and Answer
15:40-16:00 Coffee-break
Therapeutic HPV Vaccine
ÁÂÀå ³²ÁÖÇö±³¼ö (¿ï»êÀÇ´ë »êºÎÀΰú)
16:00-16:25 Review; Therapeutic HPV Vaccine
±èÂùÁÖ ±³¼ö (°¡Å縯ÀÇ´ë »êºÎÀΰú)
16:25-16:50 Update Research on Therapeutic HPV
Vaccine ÁøÇöŹ ¹Ú»ç (Æ÷Ç×°ø´ë »ý¸í°úÇкÎ)
16:50-17:00 Question and Answer
17:00-17:05 Æóȸ»ç
»çÀüµî·Ï½Åû¼
¼º ¸í (ÇѱÛ)
(¿µ¹®)
ÀÇ»ç¸éÇã¹øÈ£
Á÷ À§ ¡àÀü¹®ÀÇ ¡àÀü°øÀÇ
º´ ¿ø Àå
Àü È ¹ø È£
ÈÞ ´ë Æù
E-mail
»çÀüµî·Ï ¾È³»
n »çÀüµî·Ï : 2006³â 1¿ù 6ÀÏ
n ¿¬¼öÆòÁ¡ : 6Á¡
n ¹® ÀÇ Ã³ :
¼¿ï½Ã ¼Ãʱ¸ ¹ÝÆ÷µ¿ 505¹øÁö
TEL 02-590-1738,4941
FAX 02-594-4286
E-mail cancer@catholic.ac.kr
¢º »çÀüµî·ÏÀº ÆÑ½º¿Í À̸ÞÀϷθ¸
¹Þ½À´Ï´Ù.
»çÀüµî·ÏÀ» ÇϽźп¡ ÇÑÇÏ¿© Á¡½ÉÀÌ Á¦°øµÇ¿À´Ï ½Åû¼¸¦ ÀÛ¼ºÇϽþî
º¸³»ÁֽʽÿÀ.
´ã´çÀÚ : °³²¼º¸ðº´¿ø °¡Å縯 ¾Ï¼¾ÅÍ Á¤ÁöÀº
137-701 ¼Ãʱ¸ ¹ÝÆ÷µ¿ 505¹øÁö
Tel :02-590-1738
Fax:02-594-4286
H.P:010-3959-1049
|
1 ·
2 ·
3 ·
4 ·
5 ·
6 ·
7 ·
8 ·
9 ·
10